These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2027007

  • 21. Distribution of [3H]quinuclidinyl benzilate, [3H]nicotine, and [125I]alpha-bungarotoxin binding sites in the nucleus tractus solitarii of the cat.
    Maley BE, Seybold VS.
    J Comp Neurol; 1993 Jan 08; 327(2):194-204. PubMed ID: 8425941
    [Abstract] [Full Text] [Related]

  • 22. Differential distribution of muscarinic cholinergic and putative nicotinic cholinergic receptors within the hypothalamo-neurohypophysial system of the rat.
    Michels KM, Meeker RB, Hayward JN.
    Neuroendocrinology; 1986 Jan 08; 44(4):498-507. PubMed ID: 3822079
    [Abstract] [Full Text] [Related]

  • 23. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
    Bhat RV, Turner SL, Marks MJ, Collins AC.
    J Pharmacol Exp Ther; 1990 Oct 08; 255(1):187-96. PubMed ID: 2213555
    [Abstract] [Full Text] [Related]

  • 24. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
    Marks MJ, Farnham DA, Grady SR, Collins AC.
    J Pharmacol Exp Ther; 1993 Feb 08; 264(2):542-52. PubMed ID: 8437106
    [Abstract] [Full Text] [Related]

  • 25. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
    Nuutinen S, Ahtee L, Tuominen RK.
    Eur J Pharmacol; 2005 May 16; 515(1-3):83-9. PubMed ID: 15894304
    [Abstract] [Full Text] [Related]

  • 26. Postnatal development of cholinergic enzymes and receptors in mouse brain.
    Fiedler EP, Marks MJ, Collins AC.
    J Neurochem; 1987 Sep 16; 49(3):983-90. PubMed ID: 3612135
    [Abstract] [Full Text] [Related]

  • 27. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG, Saraswati M, Lerner-Marmarosh N, Hashmi M.
    Biochem Pharmacol; 1993 May 25; 45(10):2143-8. PubMed ID: 8512596
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
    Tani Y, Saito K, Imoto M, Ohno T.
    Eur J Pharmacol; 1998 Jun 19; 351(2):181-8. PubMed ID: 9687001
    [Abstract] [Full Text] [Related]

  • 29. Binding differences between nicotine and alpha-bungarotoxin in the rat brain.
    Nukina I, Ogawa N, Takayama H, Ota Z.
    Res Commun Chem Pathol Pharmacol; 1985 Jan 19; 47(1):141-4. PubMed ID: 2858912
    [Abstract] [Full Text] [Related]

  • 30. Localization of 3H-nicotine, 125I-kappa-bungarotoxin, and 125I-alpha-bungarotoxin binding to nicotinic sites in the chicken forebrain and midbrain.
    Sorenson EM, Chiappinelli VA.
    J Comp Neurol; 1992 Sep 01; 323(1):1-12. PubMed ID: 1430311
    [Abstract] [Full Text] [Related]

  • 31. The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice.
    Roni MA, Rahman S.
    Psychopharmacology (Berl); 2014 Aug 01; 231(15):2989-98. PubMed ID: 24682499
    [Abstract] [Full Text] [Related]

  • 32. Nicotine-induced tolerance and receptor changes in four mouse strains.
    Marks MJ, Romm E, Gaffney DK, Collins AC.
    J Pharmacol Exp Ther; 1986 Jun 01; 237(3):809-19. PubMed ID: 3712280
    [Abstract] [Full Text] [Related]

  • 33. 4-Bromoacetamidoprocaine: an affinity ligand for brain muscarinic and nicotinic cholinergic receptors.
    Saraswati M, Hashmi M, Abood LG.
    Neurochem Res; 1992 Mar 01; 17(3):247-52. PubMed ID: 1620268
    [Abstract] [Full Text] [Related]

  • 34. Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury.
    Verbois SL, Scheff SW, Pauly JR.
    Neuropharmacology; 2003 Feb 01; 44(2):224-33. PubMed ID: 12623221
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacology of lobeline, a nicotinic receptor ligand.
    Damaj MI, Patrick GS, Creasy KR, Martin BR.
    J Pharmacol Exp Ther; 1997 Jul 01; 282(1):410-9. PubMed ID: 9223582
    [Abstract] [Full Text] [Related]

  • 37. Piperidine, pyridine alkaloid inhibition of fetal movement in a day 40 pregnant goat model.
    Green BT, Lee ST, Welch KD, Pfister JA, Panter KE.
    Food Chem Toxicol; 2013 Aug 01; 58():8-13. PubMed ID: 23603380
    [Abstract] [Full Text] [Related]

  • 38. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice.
    Robinson SF, Grun EU, Pauly JR, Collins AC.
    Pharmacol Biochem Behav; 1996 Jul 01; 54(3):587-93. PubMed ID: 8743633
    [Abstract] [Full Text] [Related]

  • 39. Alteration of brain nicotinic receptors induced by immobilization stress and nicotine in rats.
    Takita M, Muramatsu I.
    Brain Res; 1995 May 29; 681(1-2):190-2. PubMed ID: 7552278
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.